BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 33441515)

  • 21. Blastic Plasmacytoid Dendritic Cell Neoplasm: A Case Report.
    Nasiri A; Lami A; Alhumaidi A; Madkhali A; Althaqib A; Aljarwan N; Alkharras R
    Cureus; 2023 Apr; 15(4):e37016. PubMed ID: 37026111
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Acute Myeloid Leukemia, Version 3.2023, NCCN Clinical Practice Guidelines in Oncology.
    Pollyea DA; Altman JK; Assi R; Bixby D; Fathi AT; Foran JM; Gojo I; Hall AC; Jonas BA; Kishtagari A; Lancet J; Maness L; Mangan J; Mannis G; Marcucci G; Mims A; Moriarty K; Mustafa Ali M; Neff J; Nejati R; Olin R; Percival ME; Perl A; Przespolewski A; Rao D; Ravandi F; Shallis R; Shami PJ; Stein E; Stone RM; Sweet K; Thota S; Uy G; Vachhani P; Cassara CJ; Freedman-Cass DA; Stehman K
    J Natl Compr Canc Netw; 2023 May; 21(5):503-513. PubMed ID: 37156478
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of diagnostic efficacy of NRP-1/CD304 in hematological diseases.
    Liu YJ; Li XH; Song YL; Zhou YC; Cai RZ; Chi PD
    Cancer Med; 2023 May; 12(10):11284-11292. PubMed ID: 36965095
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Blastic plasmacytoid dendritic cell neoplasm accompanied by chronic myelomonocytic leukemia successfully treated with azacitidine].
    Sukegawa S; Sakata-Yanagimoto M; Matsuoka R; Momose H; Kiyoki Y; Noguchi M; Nakamura N; Watanabe R; Fujimoto M; Yokoyama Y; Nishikii H; Kato T; Kusakabe M; Kurita N; Obara N; Hasegawa Y; Chiba S
    Rinsho Ketsueki; 2018; 59(12):2567-2573. PubMed ID: 30626790
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Myeloid Neoplasms with Elevated Plasmacytoid Dendritic Cell Differentiation Reflect the Maturation Process of Dendritic Cells.
    Huang Y; Wang Y; Chang Y; Yuan X; Hao L; Shi H; Lai Y; Huang X; Liu Y
    Cytometry A; 2020 Jan; 97(1):61-69. PubMed ID: 31876105
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Blastic Plasmacytoid Dendritic Cell Neoplasm: From Origin of the Cell to Targeted Therapies.
    Laribi K; Denizon N; Besançon A; Farhi J; Lemaire P; Sandrini J; Truong C; Ghnaya H; Baugier de Materre A
    Biol Blood Marrow Transplant; 2016 Aug; 22(8):1357-1367. PubMed ID: 27026248
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intracytoplasmic detection of TCL1--but not ILT7-by flow cytometry is useful for blastic plasmacytoid dendritic cell leukemia diagnosis.
    Angelot-Delettre F; Biichle S; Ferrand C; Seilles E; Gaugler B; Harrivel V; Rosenthal-Allieri MA; Deconinck E; Saas P; Garnache-Ottou F
    Cytometry A; 2012 Aug; 81(8):718-24. PubMed ID: 22674796
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment of blastic plasmacytoid dendritic cell neoplasm.
    Sullivan JM; Rizzieri DA
    Hematology Am Soc Hematol Educ Program; 2016 Dec; 2016(1):16-23. PubMed ID: 27913457
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Blastic Plasmacytoid Dendritic Cell Neoplasm in Long-Term Complete Remission After Venetoclax Monotherapy.
    Sasaki Y; Murai S; Shiozawa E; Yamochi T; Hattori N
    Cureus; 2024 Jan; 16(1):e52446. PubMed ID: 38371152
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Blastic Plasmacytoid Dendritic Cell Neoplasm Is Dependent on BCL2 and Sensitive to Venetoclax.
    Montero J; Stephansky J; Cai T; Griffin GK; Cabal-Hierro L; Togami K; Hogdal LJ; Galinsky I; Morgan EA; Aster JC; Davids MS; LeBoeuf NR; Stone RM; Konopleva M; Pemmaraju N; Letai A; Lane AA
    Cancer Discov; 2017 Feb; 7(2):156-164. PubMed ID: 27986708
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Blastic plasmacytoid dendritic cell neoplasm: update on molecular biology, diagnosis, and therapy.
    Riaz W; Zhang L; Horna P; Sokol L
    Cancer Control; 2014 Oct; 21(4):279-89. PubMed ID: 25310209
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MicroRNA profiling of blastic plasmacytoid dendritic cell neoplasm and myeloid sarcoma.
    Sapienza MR; Fuligni F; Melle F; Tabanelli V; Indio V; Laginestra MA; Motta G; Mazzara S; Cerroni L; Pileri A; Facchetti F; Paulli M; Cascione L; Laganà A; Berti E; Ferracin M; Agostinelli C; Sabattini E; Croce CM; Pileri SA
    Hematol Oncol; 2020 Dec; 38(5):831-833. PubMed ID: 33405278
    [No Abstract]   [Full Text] [Related]  

  • 33. Venetoclax in relapsed/refractory blastic plasmacytoid dendritic cell neoplasm with central nervous system involvement: a case report and review of the literature.
    Albiol N; Novelli S; Mozos A; Pratcorona M; Martino R; Sierra J
    J Med Case Rep; 2021 Jun; 15(1):326. PubMed ID: 34172079
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Plasmacytoid dendritic cell expansion defines a distinct subset of RUNX1-mutated acute myeloid leukemia.
    Xiao W; Chan A; Waarts MR; Mishra T; Liu Y; Cai SF; Yao J; Gao Q; Bowman RL; Koche RP; Csete IS; DelGaudio NL; Derkach A; Baik J; Yanis S; Famulare CA; Patel M; Arcila ME; Stahl M; Rampal RK; Tallman MS; Zhang Y; Dogan A; Goldberg AD; Roshal M; Levine RL
    Blood; 2021 Mar; 137(10):1377-1391. PubMed ID: 32871587
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Blastic Plasmacytoid Dendritic Cell Neoplasm: How do You Distinguish It from Acute Myeloid Leukemia?
    Reichard KK
    Surg Pathol Clin; 2013 Dec; 6(4):743-65. PubMed ID: 26839196
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunophenotypic analysis of myeloperoxidase-negative leukemia cutis and blastic plasmacytoid dendritic cell neoplasm.
    Cronin DM; George TI; Reichard KK; Sundram UN
    Am J Clin Pathol; 2012 Mar; 137(3):367-76. PubMed ID: 22338048
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Blastic plasmacytoid dendritic cell neoplasm: a clinicopathologic review.
    Shi Y; Wang E
    Arch Pathol Lab Med; 2014 Apr; 138(4):564-9. PubMed ID: 24678689
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Acute lymphoplasmacytoid dendritic cell (DC2) leukemia: results from the Hellenic Dendritic Cell Leukemia Study Group.
    Tsagarakis NJ; Kentrou NA; Papadimitriou KA; Pagoni M; Kokkini G; Papadaki H; Pappa V; Marinakis T; Anagnostopoulos NI; Vadikolia C; Anagnostopoulos A; Angelopoulou MK; Terpos E; Poziopoulos C; Anargyrou K; Rontogianni D; Papadaki T; Psarra A; Kontopidou FN; Skoumi D; Papadhimitriou SI; Paterakis G;
    Leuk Res; 2010 Apr; 34(4):438-46. PubMed ID: 19793612
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) in an Elderly Female: A Rare Case.
    Al-Alwan A; Khalid F; Vyas C; Sirpal V; Bader H
    J Community Hosp Intern Med Perspect; 2023; 13(4):79-81. PubMed ID: 37868236
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Plasmacytoid Dendritic Cells, a Novel Target in Myeloid Neoplasms.
    Roussel X; Garnache Ottou F; Renosi F
    Cancers (Basel); 2022 Jul; 14(14):. PubMed ID: 35884612
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.